These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 27238755)
1. EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes. Mani SK; Zhang H; Diab A; Pascuzzi PE; Lefrançois L; Fares N; Bancel B; Merle P; Andrisani O J Hepatol; 2016 Nov; 65(5):888-898. PubMed ID: 27238755 [TBL] [Abstract][Full Text] [Related]
2. Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein. Studach LL; Menne S; Cairo S; Buendia MA; Hullinger RL; Lefrançois L; Merle P; Andrisani OM Hepatology; 2012 Oct; 56(4):1240-51. PubMed ID: 22505317 [TBL] [Abstract][Full Text] [Related]
3. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis. Zhang H; Xing Z; Mani SK; Bancel B; Durantel D; Zoulim F; Tran EJ; Merle P; Andrisani O Hepatology; 2016 Oct; 64(4):1033-48. PubMed ID: 27338022 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. Fan H; Zhang H; Pascuzzi PE; Andrisani O Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells. Mani SKK; Andrisani O Genes (Basel); 2018 Mar; 9(3):. PubMed ID: 29498629 [TBL] [Abstract][Full Text] [Related]
6. Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma. Mani SKK; Yan B; Cui Z; Sun J; Utturkar S; Foca A; Fares N; Durantel D; Lanman N; Merle P; Kazemian M; Andrisani O Theranostics; 2020; 10(24):10957-10972. PubMed ID: 33042264 [No Abstract] [Full Text] [Related]
7. PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis. Zhang H; Diab A; Fan H; Mani SK; Hullinger R; Merle P; Andrisani O Cancer Res; 2015 Jun; 75(11):2363-74. PubMed ID: 25855382 [TBL] [Abstract][Full Text] [Related]
8. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway. Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189 [TBL] [Abstract][Full Text] [Related]
9. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection. Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7. Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223 [TBL] [Abstract][Full Text] [Related]
12. Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness. Lai HC; Chung WM; Chang CM; Liao PY; Su YT; Yeh CC; Jeng LB; Ma WL; Chang WC Anticancer Res; 2020 Mar; 40(3):1285-1295. PubMed ID: 32132025 [TBL] [Abstract][Full Text] [Related]
13. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
14. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma. Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells. Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240 [TBL] [Abstract][Full Text] [Related]
17. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Yamashita T; Budhu A; Forgues M; Wang XW Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828 [TBL] [Abstract][Full Text] [Related]
18. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B. Wang X; Oishi N; Shimakami T; Yamashita T; Honda M; Murakami S; Kaneko S World J Gastroenterol; 2017 May; 23(18):3252-3261. PubMed ID: 28566884 [TBL] [Abstract][Full Text] [Related]
20. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. Terris B; Cavard C; Perret C J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]